Biocon Limited has informed the Exchange regarding a press release dated February 04, 2021, titled "Biocon Biologics to offer its Oncology Biosimilars through Cancer Access Partnership in over 30 countries, Will enable access to Trastuzumab & Pegfilgrastim in Africa & Asia".